Influenza and Other Respiratory Viruses | |
Overview of the 3rd isirv‐Antiviral Group Conference – advances in clinical management | |
Aeron C. Hurt1  David S. Hui3  Alan Hay2  | |
[1] WHO Collaborating Centre for Reference and Research on Influenza, VIDRL at the Peter Doherty Institute for Infection and Immunity, Parkville, Vic., Australia;National Institute for Medical Research, Mill Hill, London, UK;Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong | |
关键词: Antivirals; clinical management; immunocompromised; influenza; respiratory; treatment; | |
DOI : 10.1111/irv.12293 | |
来源: Wiley | |
【 摘 要 】
This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.Abstract
【 授权许可】
CC BY
© 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202107150012414ZK.pdf | 155KB | download |